Prescription medication · Androgen Hormone
testosterone
Also sold as AndroGel, Testim. Testosterone pellets treat low testosterone in men.
Data updated 2026-05-15
- 40,954
- FDA reportsOften reported
- 2
- InteractionsFew interactions
- 71% less
- Generic vs brandBig savings
- In shortage
- FDA status
What the data shows
testosterone (AndroGel) is a prescription Androgen Hormone, reported at a middle-of-the-pack volume (40,954 FDA reports), whose generic runs roughly half the brand price or less (71% less).
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
testosterone (AndroGel) is a prescription Androgen Hormone. Testosterone pellets treat low testosterone in men.
Testosterone pellets (Testopel) are a hormone replacement therapy. They help men who don't produce enough testosterone on their own.
Verify with FDA → · CMS NADAC pricing →
Drug Shortage Alert
testosterone is currently listed as to be discontinued by the FDA. Affected manufacturer: Actavis Pharma, Inc..
View all drug shortages →Drug Pricing (NADAC)
Brand Price
$3.79/unit
Generic Price
$1.10/unit
Generic Savings
71%
Generic Available
Yes (30 manufacturers)
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
Testosterone pellets treat low testosterone in men.
Common side effects
Acne, Male-pattern baldness, Increased or decreased sex drive
Key warnings
Testosterone pellets can cause blood clots in your veins.
The sections below are summarized in plain English from testosterone's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Testosterone is a male sex hormone. These pellets are implanted under the skin and slowly release testosterone into your body. This helps to restore normal testosterone levels.
How to Take It
Your doctor will insert the testosterone pellets under your skin. The number of pellets you get depends on how much testosterone you need. You will likely get them every 3 to 6 months. Make sure to follow your doctor's instructions carefully.
This is a plain-language summary of testosterone's FDA labeling, not individualized dosing advice. Ask a pharmacist or prescriber before changing how you take this medication.
Pregnancy & Breastfeeding
Testosterone can harm an unborn baby. You should not use this medicine if you are pregnant or may become pregnant. Talk to your doctor if you have any questions.
This is a plain-language summary of testosterone's FDA labeling, not individualized advice. Ask a pharmacist or prescriber about pregnancy or breastfeeding on this medication.
Missed Dose
Since the pellets are implanted, you don't have to worry about a missed dose. Talk to your doctor if you think the pellets are not working anymore.
This is a plain-language summary of testosterone's FDA labeling, not individualized advice. Ask a pharmacist or prescriber what to do about your specific missed dose.
Storage
Store at room temperature, away from heat and moisture.
Side Effects (from patient reports)
Based on 40,954 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for testosterone, by number of reports
- Heart attack
Heart attack
3,269 reports
- Pain
Pain
2,379 reports
- Blood clot in a deep vein
Blood clot in a deep vein
2,176 reports
- Testosterone level decreased
Testosterone level decreased
2,093 reports
- Stroke
Stroke
2,091 reports
- Blood clot in the lungs
Blood clot in the lungs
2,028 reports
- Tiredness
Tiredness
2,004 reports
- Anxiety
Anxiety
1,647 reports
- Weakness
Weakness
1,440 reports
- Financial difficulties 1,209
Financial difficulties
1,209 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Reports over time
Adverse-event reports filed for testosterone each year to the FDA Adverse Event Reporting System (FAERS).
Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.
Where testosterone sits
testosterone has more FDA adverse-event reports than 70% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.
Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is testosterone; the line is the median (50th percentile).
FDA Adverse Event Report Analysis
Detailed analysis of 40,954 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.
Total Reports
40,954
Reports Mentioning Death
1,852
4.5% of reports — not proof of cause
Hospitalization Reports
9,033
Top Indication
Product Used For Unknown Indication
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 1 | MYOCARDIAL INFARCTION | 3,269 |
| 3 | PAIN | 2,379 |
| 4 | DEEP VEIN THROMBOSIS | 2,176 |
| 5 | BLOOD TESTOSTERONE DECREASED | 2,093 |
| 6 | CEREBROVASCULAR ACCIDENT | 2,091 |
| 7 | PULMONARY EMBOLISM | 2,028 |
| 8 | FATIGUE | 2,004 |
| 9 | ANXIETY | 1,647 |
| 11 | ASTHENIA | 1,440 |
| 12 | ECONOMIC PROBLEM | 1,209 |
| 13 | HEADACHE | 1,182 |
| 14 | NAUSEA | 1,178 |
| 15 | EMOTIONAL DISTRESS | 1,034 |
| 16 | INJURY | 1,023 |
| 17 | THROMBOSIS | 976 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
Testosterone pellets can cause blood clots in your veins. This includes clots in your legs (deep vein thrombosis) and lungs (pulmonary embolism). Tell your doctor right away if you have pain, swelling, warmth, or redness in your leg, or if you have trouble breathing or chest pain.
Known Drug Interactions
However, clinical studies have shown that lovastatin does not reduce basal plasma cortisol concentration or impair adrenal reserve, and does not reduce basal plasma testosterone concentration. Another HMG-CoA reductase inhibitor has been shown to reduce the plasma testosterone response to HCG. In the same study, the mean testosterone response to HCG was slightly but not significantly reduced after treatment with lovastatin 40 mg daily for 16 weeks in 21 men.
Mechanism: Lovastatin does not significantly lower the amount of testosterone in your blood or stop your body from making it.
What to do: You can take these medications together without any special monitoring or dose changes.
The following laboratory tests may be affected by progestins including medroxyprogesterone acetate injectable suspension: (a) Plasma and urinary steroid levels are decreased (e.g., progesterone, estradiol, pregnanediol, testosterone, cortisol).
Mechanism: Medroxyprogesterone can lower the amount of testosterone found in your blood and urine.
What to do: Your doctor may need to monitor your hormone levels or adjust your dosage if you take these together.
This is a plain-language summary of interactions documented in FDA labeling, not individualized advice. Ask a pharmacist or prescriber before combining medications.
Common Questions
What if I experience prolonged erections?
Can this medicine cause liver problems?
Will this medicine affect my fertility?
Can this medicine cause mood changes?
How often will I need to get the pellets implanted?
Can this medicine cause my body to retain fluid?
Can testosterone pellets be used for age-related low testosterone?
What should I do if the implantation site gets infected?
Can this medication cause breast enlargement?
Can this medication cause changes in my skin?
What are the common side effects of testosterone?
Does testosterone interact with other medications?
What drug class is testosterone?
Is there a generic version of testosterone?
Is testosterone safe during pregnancy?
Has testosterone been recalled?
Is testosterone currently in shortage?
Active Recalls
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Defective Container - A defect in the side-seal which allows leakage of product.
Teva Pharmaceuticals USA, Inc
CGMP Deviations: Potential presence of metal particulate matter
FARMAKEIO OUTSOURCING LLC
CGMP Deviations: Potential presence of metal particulate matter
FARMAKEIO OUTSOURCING LLC
Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets.
Advanced Pharmaceutical Technology, Inc.
Labeling: Incorrect or Missing Lot and/or Exp. Date: A printing issue resulted in incorrect lot numbers on the label.
Qualgen, LLC
Presence of Particulate Matter: Glass particles were found in pellet vials.
BSO LLC
cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.
Eugia US LLC
Superpotent Drug
Teva Pharmaceuticals USA, Inc
Lack of Assurance of Sterility
TMC Acquisition LLC dba Tailor Made Compounding
Lack of Assurance of Sterility
TMC Acquisition LLC dba Tailor Made Compounding
Lack of Assurance of Sterility
TMC Acquisition LLC dba Tailor Made Compounding
Lack of Assurance of Sterility
Tri-Coast Pharmacy
Lack of Assurance of Sterility
Tri-Coast Pharmacy
Lack of Assurance of Sterility
Tri-Coast Pharmacy
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Related Medications in Androgen Hormone
Other drugs grouped near testosterone - same-class peers and common alternatives.
abiraterone
Zytiga
Abiraterone (Zytiga) is a medicine used with prednisone to treat prostate cancer that has spread.
Compare with testosterone →
anastrozole
Arimidex
Anastrozole is a medicine used to treat breast cancer in women after menopause.
Compare with testosterone →
bazedoxifene/conjugated estrogens
Duavee
Duavee is a combination medicine containing estrogen and a drug that blocks estrogen in some parts of the body.
Compare with testosterone →
cabergoline
Dostinex
Cabergoline is a medicine that helps lower the amount of prolactin in your body.
Compare with testosterone →
clomiphene
Clomid, Serophene
Clomiphene citrate is a medicine that helps women ovulate.
Compare with testosterone →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
Why some drugs demand precise dosing and monitoring
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on testosterone
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for testosterone
The FDA label for testosterone (sold under brand names such as AndroGel, Testim) classifies it as a prescription-only medication in the Androgen Hormone class. Testosterone pellets treat low testosterone in men. Official labeling lists 8 commonly reported side effects, including Acne, Male-pattern baldness, Increased or decreased sex drive.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 40,954 voluntary reports. The database also lists 2 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated minor severity. NADAC pricing from CMS shows a generic unit cost of $1.10 versus $3.79 for the brand - a 71% generic savings.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history (currently 28 recall records on file), and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice, always consult a licensed healthcare provider before starting, stopping, or changing any medication.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC). Shortage status: FDA Drug Shortages Database.
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.
Last updated: July 17, 2025
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled and last refreshed May 2026. See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages